O Vérola

4.0k total citations · 1 hit paper
83 papers, 2.7k citations indexed

About

O Vérola is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, O Vérola has authored 83 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 24 papers in Epidemiology and 23 papers in Dermatology. Recurrent topics in O Vérola's work include Cutaneous lymphoproliferative disorders research (12 papers), Autoimmune Bullous Skin Diseases (8 papers) and Histiocytic Disorders and Treatments (8 papers). O Vérola is often cited by papers focused on Cutaneous lymphoproliferative disorders research (12 papers), Autoimmune Bullous Skin Diseases (8 papers) and Histiocytic Disorders and Treatments (8 papers). O Vérola collaborates with scholars based in France, United States and Switzerland. O Vérola's co-authors include Louis Dubertret, Patrice Morel, H. Bachelez, M. Viguier, Laurent Ferradini, Guy Gorochov, Philippe Kourilsky, Fabrice Lemaı̂tre, Célèste Lebbé and Fabien Calvo and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

O Vérola

78 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells

2004 561 citations M. Viguier, Fabrice Lemaı̂tre et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by O Vérola

Since Specialization

Citations

This map shows the geographic impact of O Vérola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Vérola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Vérola more than expected).

Fields of papers citing papers by O Vérola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Vérola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Vérola. The network helps show where O Vérola may publish in the future.

Co-authorship network of co-authors of O Vérola

This figure shows the co-authorship network connecting the top 25 collaborators of O Vérola. A scholar is included among the top collaborators of O Vérola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Vérola. O Vérola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumeur trichilemmale proliférante de la région ischio-rectale 2011 ·Annales de Pathologie ·(unknown), O Vérola, A. Senéjoux, (unknown), Benoît Terris, André Balaton, Vincent Molinié	4
2	Viability of cryopreserved human skin allografts: effects of transport media and cryoprotectant 2011 ·Cell and Tissue Banking ·Sonia Gaucher, Caroline Elie, O Vérola, Mohamed Jarraya	30
3	Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients 2010 ·Clinical Cancer Research ·Delphine Kérob, Raphaël Porcher, O Vérola, Stéphane Dalle, E. Maubec, F. Aubin, M. D’Incan, (unknown), S. Boulinguez, Isabelle Madelaine‐Chambrin, A. Mathieu-Boué, Jean-Marie Servant, É. de Kerviler, Anne Janin, Fabien Calvo, Florence Pédeutour, Célèste Lebbé	98
4	Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis 2009 ·Melanoma Research ·Isabelle Martins, (unknown), Frédérique Deshayes, Jessica Lauriol, Stéphanie Ghislin, Marie‐Caroline Dieu‐Nosjean, M. Viguier, O Vérola, Dominique Charron, Catherine Alcaïde‐Loridan, Reem Al‐Daccak	19
5	Slow Dynamic Lymphoscintigraphy Is Not a Reliable Predictor of Sentinel-Node Negativity in Cutaneous Melanoma 2008 ·Cancer Biotherapy and Radiopharmaceuticals ·Marie‐Elisabeth Toubert, Pierre‐Alexandre Just, Georges Baillet, Delphine Kérob, Elif Hindié, O Vérola, M. Revol, Jean-Marie Servant, Nicole Basset‐Séguin, Célèste Lebbé, Elena Banti, Domenico Rubello, Jean‐Luc Moretti	5
6	Kaposi's sarcoma in HIV-negative men having sex with men 2008 ·AIDS ·Fanny Lanternier, Célèste Lebbé, Noël E.C. Schartz, David Farhi, Anne‐Geneviève Marcelin, Delphine Kérob, F. Agbalika, O Vérola, Isabelle Gorin, Michel Janier, Marie‐Françoise Avril, N. Dupin	55
7	Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma 2008 ·British Journal of Dermatology ·A. Dupuy, Thomas F. Schulz, Sylvie Chevret, F. Agbalika, C Pellet, M. Janier, N. Dupin, O Vérola, Fabien Calvo, Célèste Lebbé	7
8	[Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. 2006 ·PubMed ·Sylvie Négrier, Philippe Saïag, B. Guillot, O Vérola, Marie‐Françoise Avril, Christiane Bailly, Didier Cupissol, S. Dalac, A. Danino, Brigitte Dréno, Jean‐Jacques Grob, M.‐T. Leccia, C. Renaud-Vilmer, L. Bosquet	20
9	Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells breakdown → 2004 ·The Journal of Immunology ·M. Viguier, Fabrice Lemaı̂tre, O Vérola, (unknown), Guy Gorochov, Louis Dubertret, H. Bachelez, Philippe Kourilsky, Laurent Ferradini	561
10	High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma 2004 ·Bone Marrow Transplantation ·S. Oro, H. Bachelez, O Vérola, Célèste Lebbé, Jean Pierre Marolleau, Christophe Hennequin, Louis Dubertret, Pierre Morel, Christian Gisselbrecht, Pauline Brice	18
11	Carcinoma of the penis arising in differentiated epithelialdysplasia associated with lichen sclerosus 2000 ·European Journal of Dermatology ·C Vilmer, (unknown), B. Cavelier‐Balloy, Sylvie M. Guichard, O Vérola, Louis Dubertret	3
12	Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcoma 1998 ·AIDS ·Célèste Lebbé, L. Blum, C Pellet, (unknown), O Vérola, Patrice Morel, O Danne, Fabien Calvo	213
13	CORRELATION OF GRANULOMA STRUCTURE WITH CLINICAL OUTCOME DEFINES TWO TYPES OF IDIOPATHIC DISSEMINATED BCG INFECTION 1997 ·The Journal of Pathology ·Jean‐François Emile, Natacha Patey, Frédéric Altare, Salma Lamhamedi, Emmanuelle Jouanguy, (unknown), (unknown), (unknown), O Vérola, (unknown), Frédérique Dijoud, S. Blanche, ALAIN FISCHER, Nicole Brousse, Jean‐Laurent Casanova	103
14	Cutaneous T-Cell Lymphoma Associated with Granulomatous Slack Skin 1996 ·Dermatology ·F. Mouly, M. Baccard, JM Cayuela, (unknown), O Vérola, B. Flageul, Patrice Morel	22
15	Unusual specific cutaneous lesions in myelodysplastic syndromes 1995 ·Journal of the American Academy of Dermatology ·S. Aractingi, Claude Bachmeyer, (unknown), O Vérola, Philippe Rousselot, Louis Dubertret, Marie Thérèse Daniel	31
16	Umbilical Paget's disease and prostatic carcinoma 1993 ·British Journal of Dermatology ·(unknown), S. Aractingi, F.–X. Blanc, O Vérola, Dominique Vignon, Louis Dubertret	15
17	Persistent acantholytic dermatosis: sex/related differences in clinical presentation? 1993 ·Acta Dermato Venereologica ·M. Mokni, S. Aractingi, Rachel Grossman, O Vérola, (unknown), J Civatte, Louis Dubertret	9
18	Acral Persistent Papular Mucinosis and IgA Monoclonal Gammopathy: Report of a Case 1992 ·Dermatology ·Luca Borradori, S. Aractingi, F.–X. Blanc, O Vérola, Louis Dubertret	14
19	Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with amicrobial lymph node suppuration and aseptic spleen abscesses 1988 ·British Journal of Dermatology ·(unknown), (unknown), (unknown), M. Rybojad, O Vérola, Patrice Morel, J Modaï, A Puissant	29
20	[Sea-blue histiocytes and storage diseases. 3 cases]. 1985 ·PubMed ·Isabelle Aubert, (unknown), (unknown), (unknown), O Vérola, C Brochériou, A Lageron, J Rouffy	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact